Chugh, R., Ballman, K. V., Helman, L. J., Patel, S., Whelan, J. S., Widemann, B., . . . Strauss, S. J. (2020). SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma. Cancer.
Citação norma ChicagoChugh, Rashmi, et al. "SARC025 Arms 1 and 2: A Phase 1 Study of the Poly(ADP‐ribose) Polymerase Inhibitor Niraparib With Temozolomide or Irinotecan in Patients With Advanced Ewing Sarcoma." Cancer 2020.
Citação norma MLAChugh, Rashmi, et al. "SARC025 Arms 1 and 2: A Phase 1 Study of the Poly(ADP‐ribose) Polymerase Inhibitor Niraparib With Temozolomide or Irinotecan in Patients With Advanced Ewing Sarcoma." Cancer 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.